===
Sartorius Stedim Biotech SA
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED
CAPITAL
04-Jun-2024 / 10:10 CET/CEST
Dissemination of a French Regulatory News, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


Sartorius Stedim Biotech S.A. - 13781 Aubagne Cedex, France





DECLARATION RELATIVE TO
THE NUMBER OF SHARES AND VOTING RIGHTS
MAKING UP THE ISSUED CAPITAL

Article L 233-8-II of the Code of commerce
and article 223-6 of the general regulations of the AMF




Designation of issuer



SARTORIUS STEDIM BIOTECH SA
CS 91051
Z. I. Les Paluds
Avenue de Jouques
13781 Aubagne Cedex

Date of       Total number of shares making up    Total number of theoretical voting rights      Total number of net 
information   the issued capital                  including treasury shares                      voting rights 

May 31, 2024 97,330,405 165,579,822 165,540,665
===
-----------------------------------------------------------------------------------------------------------------------

Regulatory filing PDF file File: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL

===

Language:     English 
Company:      Sartorius Stedim Biotech SA 

Avenue de Jouques
13781 Aubagne
France

Phone:        +33 44 284 5600 
E-mail:       sartorius.presse@sartorius.com 
Internet:     www.sartorius-stedim.com 
ISIN:         FR0013154002 
Euronext      DIM 

Ticker:
AMF Category: Total number of voting rights and share capital / Information on the total number of voting rights and
the number of shares making up the share capital
EQS News ID: 1917627

End of Announcement EQS News Service
===
1917627 04-Jun-2024 CET/CEST

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1917627&application_name=news

END) Dow Jones Newswires

June 04, 2024 04:11 ET (08:11 GMT)